Medical Devices

Membrane Microfiltration Market Expected to Reach $12,858 Million, Globally, by 2022

Posted on Updated on

Membrane Microfiltration Market Report, published by Allied Market Research, forecasts that the global market was valued at $6,769 million in 2015, and is expected to reach $12,858 million by 2022, supported by a CAGR of 9.6% during the forecast period 2014 – 2022.

Enquire more about the report: https://www.alliedmarketresearch.com/request-free-sample/1886

The cross-flow segment accounted for more than half of the market share of the global market in 2015, owing to the varied use of this filtration technique in several industries such as water & waste water treatment, pharmaceuticals & biopharmaceutical, food & beverage, hospitals & laboratories, and others. The water & waste water treatment segment accounted for more than one-third share of the global market in 2015, owing to the increase in the desalination and water recycling in the developing countries.

By geography, Asia-Pacific dominated the global market with more than one-third share in 2015, owing to the rise in water & waste water treatment plants in the region, increase in food processing industry in the region, and growth in the manufacturing and R&D facilities of different pharmaceutical and biopharmaceutical companies in the region. In addition, there is a significant increase in the well-equipped laboratories for diagnostic purposes to meet the needs of the patients, which is expected to increase the demand for microfilters.

To get more insights of the market study, connect to analyst: https://www.alliedmarketresearch.com/connect-to-analyst/1886

Key Findings of Membrane Microfiltration Market

• In 2015, the cross-flow filtration mode segment accounted for half of the share of the global market.
• The organic material segment contributed the highest revenue to the global market in 2015.
• The water and waste water treatment segment is projected to grow at the fastest CAGR of 10.4% during the forecast period.
• Asia-Pacific market is projected to grow at a CAGR of 10.0% from 2016 to 2022.
The major companies profiled in the report include EMD Millipore Corporation, Koch Membrane Systems Inc., GE Water & Process Technologies, 3M Purification Solutions, Alfa Laval AB., Hyflux Ltd, Kubota Corp. Pentair plc, Danaher Corp. (Pall Corp.), and Sartorius Stedim Biotech S.A.

Implantable Defibrillators Market to Reach $8,449 Million, Globally, by 2022

Posted on Updated on

Implantable Defibrillators Market Report, published by Allied Market Research, forecasts that the global market was valued at $6,006 million in 2015 and is expected to garner $8,449 million by 2022, registering a CAGR of 4.9% during the forecast period 2016 – 2022. Transvenous implantable cardioverter defibrillators (T-ICDs) segment accounted for more than half of the global market in 2015.

Enquire more about the report: https://www.alliedmarketresearch.com/request-free-sample/2091

Implantable defibrillators are used to prevent sudden death in patients who sustained atrial fibrillation or ventricular tachycardia. These devices are implanted inside the patients body and are able to perform defibrillation, pacing of the heart, and cardioversion. The irregular heart rhythms that require ICD implant include bradycardia, ventricular tachycardia, and ventricular fibrillation.

Surge in geriatric population; increase in prevalence of chronic health conditions such as cardiac arrhythmia, ventricular fibrillation, and pulseless ventricular tachycardia, growth in preference for S-ICDs, and rise in in awareness among patients about implantable defibrillators are expected to drive the market growth. However, lack of awareness towards the availability of implantable defibrillator to prevent sudden cardiac arrest (SCA) and adoption of these devices in low- and middle-income economies are projected to hamper the market growth.

Implantable_cardioverter_defibrillator_with_lead

Transvenous implantable cardioverter-defibrillator (T-ICDs) segment dominated the global market in 2015, in terms of value, and is expected to maintain this trend throughout the analysis period. T-ICDs are the most commonly for the treatment of heart disorders for higher precision and targeted functioning. However, in terms of volume, CRT-D is projected to lead the market, reaching 1,127 thousand units by 2022, registering a CAGR of 8.9%.

North America led the global market in 2015, and is expected to maintain its dominance during the forecast period. This is attributed to the rise in incidence of sudden cardiac arrest (SCA), increase in adoption of S-ICDs, high purchasing power, and availability of advanced healthcare facilities.

To get more insights of the market study, connect to analyst: https://www.alliedmarketresearch.com/connect-to-analyst/2091

Key Findings of Implantable Defibrillators Market

• In 2015, T-ICDs led the overall implantable defibrillator market revenue, and is projected to grow at a CAGR of 4.9% during the forecast period.
• The CRT-D segment occupied the highest share in 2015, and is expected to grow at a CAGR of 8.9%, in terms of volume.
• North America was the leading consumer of implantable defibrillators in 2015, both in terms of value and volume, followed by Europe.
• Japan is expected to lead market in the Asia-Pacific region, growing at a CAGR 6.2%.

Key players operating in the market include Boston Scientific Corporation, LivaNova PLC Company, Imricor Medical Systems, MicroPort Scientific Corporation, Mayo Clinic US, Medtronic plc, MRI Interventions, Inc., St. Jude Medical, Inc., Biotronik Se & Co.KG, and Sorin Group.

Implantable Defibrillators Market to Reach $8,449 Million, Globally, by 2022

Posted on Updated on

Implantable Defibrillators Market Report, published by Allied Market Research, forecasts that the global market was valued at $6,006 million in 2015 and is expected to garner $8,449 million by 2022, registering a CAGR of 4.9% during the forecast period 2016 – 2022. Transvenous implantable cardioverter defibrillators (T-ICDs) segment accounted for more than half of the global market in 2015.

Access Full Summary:  https://www.alliedmarketresearch.com/implantable-defibrillators-market

Implantable defibrillators are used to prevent sudden death in patients who sustained atrial fibrillation or ventricular tachycardia. These devices are implanted inside the patient’s body and are able to perform defibrillation, the pacing of the heart, and cardioversion. The irregular heart rhythms that require ICD implant include bradycardia, ventricular tachycardia, and ventricular fibrillation.

implant Defibrillators

Surge in geriatric population; increase in the prevalence of chronic health conditions such as cardiac arrhythmia, ventricular fibrillation, and pulseless ventricular tachycardia, growth in preference for S-ICDs, and rise in in awareness among patients about implantable defibrillators are expected to drive the market growth. However, lack of awareness towards the availability of implantable defibrillator to prevent sudden cardiac arrest (SCA) and adoption of these devices in low- and middle-income economies are projected to hamper the market growth.

Transvenous implantable cardioverter-defibrillator (T-ICDs) segment dominated the global market in 2015, in terms of value, and is expected to maintain this trend throughout the analysis period. T-ICDs are the most commonly for the treatment of heart disorders for higher precision and targeted functioning. However, in terms of volume, CRT-D is projected to lead the market, reaching 1,127 thousand units by 2022, registering a CAGR of 8.9%.

North America led the global market in 2015 and is expected to maintain its dominance during the forecast period. This is attributed to the rise in the incidence of sudden cardiac arrest (SCA), an increase in adoption of S-ICDs, high purchasing power, and availability of advanced healthcare facilities.

To Enquire more about the report: https://www.alliedmarketresearch.com/request-free-sample/2091

Key Findings of Implantable Defibrillators Market

• In 2015, T-ICDs led the overall implantable defibrillator market revenue and is projected to grow at a CAGR of 4.9% during the forecast period.
• The CRT-D segment occupied the highest share in 2015, and is expected to grow at a CAGR of 8.9%, in terms of volume.
• North America was the leading consumer of implantable defibrillators in 2015, both in terms of value and volume, followed by Europe.
• Japan is expected to lead market in the Asia-Pacific region, growing at a CAGR 6.2%.
Key players operating in the market include Boston Scientific Corporation, LivaNova PLC Company, Imricor Medical Systems, MicroPort Scientific Corporation, Mayo Clinic US, Medtronic plc, MRI Interventions, Inc., St. Jude Medical, Inc., Biotronik Se & Co.KG, and Sorin Group.

Negative Pressure Wound Therapy (NPWT) Devices Market – Smart Strategies of the Research and Development Process

Posted on Updated on

Allied Market Research adds “Negative Pressure Wound Therapy (NPWT) Devices Market” new report to its research database. The report provides a comprehensive analysis of current & future trends and emerging avenues for the growth of this market globally.

Negative Pressure Wound Therapy Devices Market report, published by Allied Market Research, forecasts that the global market is expected to garner $2,746 million by 2022, growing at a CAGR of 4.0% during the period 2016 – 2022. North America was the leading regional market in world NPWT devices industry. The conventional NPWT devices segment is expected to maintain its lead throughout the forecast period.

Get PDF Brochure sample report @ https://www.alliedmarketresearch.com/request-free-sample/434

NPWT market growth is driven by various factors such as increase in incidence of chronic diseases such as diabetes mellitus and obesity, and development of cost-effective and portable NPWT devices. Rise in geriatric population and awareness among individuals regarding the NPWT devices have further propelled market growth. However, lack of trained physicians and healthcare services in developing countries hamper the market growth.

For instance, in May 2010, KCI obtained reimbursement approval for the product V.A.C ATS therapy by Japan’s Health Insurance Bureau. Moreover, in Europe, countries such as Germany, Sweden, and Austria offer reimbursement policies for in- and outpatient sectors in NPWT devices.

Send Enquiry About Report: https://www.alliedmarketresearch.com/purchase-enquiry/434

NPWT devices market for chronic wounds is projected to grow with the highest CAGR of 4.0%, due to the increase in incidence of chronic diseases such as diabetes mellitus. Diabetic foot ulcer is the fastest growing segment in chronic wounds, owing to rise in prevalence of diabetes mellitus. In acute wounds, surgical wounds segment is expected to be the grow at the fastest rate on account of their increasing incidence. In end-user segment, hospitals & clinics occupied the major share of the NPWT devices market, as they provide better healing of transplanted skin and fewer chances of infection in case of patients with open wounds. Home care settings was the other dominant application segment, expected to grow at a CAGR of 5.1%.

For any Queries Connect to Analyst: https://www.alliedmarketresearch.com/connect-to-analyst/434

In 2015, Germany was the leading country market in Europe and projected to maintain this trend throughout analysis period.

North America accounted for a major share in the world NPWT devices in 2015, and is expected to maintain this trend throughout the forecast period. This is attributed to the rise in the prevalence of chronic wounds, increase in awareness among patients regarding cost-effective NPWT devices, and presence of advanced healthcare facilities. However, Asia-Pacific is expected to be grow at the fastest rate, owing to presence of ample growth opportunities in terms of unmet medical needs for the treatment of burns and surgical wounds, and high rate of chronic diseases such as diabetes mellitus.

The key players profiled in this report include Acelity, Smith & Nephew, ConvaTec Inc., Mlnlycke Health Care, Coloplast, Cardinal Health, Medela AG, Paul Hartmann AG, Devon Medical, and Talley Group Limited.

About Allied Market Research:

Allied Market Research (AMR) is a full-service market research and business-consulting wing of Allied Analytics LLP based in Portland, Oregon. Allied Market Research provides global enterprises as well as medium and small businesses with unmatched quality of “Market Research Reports” and “Business Intelligence Solutions”. AMR has a targeted view to provide business insights and consulting to assist its clients to make strategic business decisions and achieve sustainable growth in their respective market domain.

Contact Us:

5933 NE Win Sivers Drive,
#205, Portland, OR 97220,
United States.
Int’l:       +1-503-894-6022
Toll Free:   +1-800-792-5285
Fax:   +1-800-792-5285
help@alliedmarketresearch.com

Breast Imaging Technologies Market – 2014-2022 Key findings by Allied Market Research

Posted on Updated on

Breast Imaging Technologies

Allied Market Research adds “Breast Imaging Technologies Market” new report to its research database. The report provides a comprehensive analysis of current & future trends and emerging avenues for the growth of this market globally.

Ionizing Breast Imaging Technologies market accounted for major share of the global market in 2015, owing to their ability to detect breast cancer in early stages, thus increasing the chances of survival. Moreover, advancements in breast imaging tools facilitate faster interpretation of breast tissue and generate less false positive results as compared to MRI, which further accelerates the market growth. Non-ionizing imaging technologies are projected to grow with the highest CAGR, due to the introduction of better imaging modalities such as automated whole breast ultrasound system (ABUS). In addition, unlike ionizing breast imaging technologies, these techniques use infrared radiations, reducing the risk of developing radiation-induced cancer, which is thus anticipated to witness an increased demand in future.

Request sample report @ https://goo.gl/noCSJD

Breast Imaging Technologies Market Report, published by Allied Market Research, forecasts that the global market is expected to garner $4,502 million by 2022, registering a CAGR of 8.4% during the period 2016-2022.North America and Europe together accounted for over three-fourths market share in 2015. Ionizing breast imaging technology is expected to maintain its lead throughout the forecast period.

Full-field digital mammography systems segment contributed for the major market share in 2015, as the technique is time efficient and utilizes a lesser radiation dose than film mammography. Moreover, the radiologists can adjust the darkness or brightness of the breast image due to which it is easier to observe differences between breast tissues in digital mammography.

Send Enquiry About Report: https://goo.gl/EIHqYr

3D breast tomosynthesis segment is projected to grow at the fastest rate during the forecast period, as this imaging technology facilitates easy detection of breast cancer in women with dense breast tissues.

Breast MRI segment dominated the non-ionizing breast imaging technologies market in 2015, owing to the associated benefits such as visualization of the breast in any orientation, which makes it highly sensitive to small abnormalities; while the breast ultrasound is anticipated to grow with the highest CAGR from 2016 to 2022.

About Allied Market Research:

Allied Market Research (AMR) is a full-service market research and business-consulting wing of Allied Analytics LLP based in Portland, Oregon. Allied Market Research provides global enterprises as well as medium and small businesses with unmatched quality of “Market Research Reports” and “Business Intelligence Solutions”. AMR has a targeted view to provide business insights and consulting to assist its clients to make strategic business decisions and achieve sustainable growth in their respective market domain.

Contact Us:

5933 NE Win Sivers Drive,
#205, Portland, OR 97220,
United States.
Int’l:       +1-503-894-6022
Toll Free:   +1-800-792-5285
Fax:   +1-800-792-5285
help@alliedmarketresearch.com

Dental Implants & Prosthetics Market – Revenue and Market Share Opportunities and Forecasts, 2014 – 2022

Posted on Updated on

Allied Market Research adds “World Dental Implants & Prosthetics Market” new report to its research database. The report provides a comprehensive analysis of current & future trends and emerging avenues for the growth of this market globally.

A dental implant is a metal post or a frame which is used in surgical procedures to connect a dental prosthetic such as crown, bridge, denture and facial prosthesis with the jaw or skull bone. Dental implants also act as orthodontic anchors. Once implanted, the dental implants cannot be visualized, much the similar way as roots are not visible externally. Hence, dental implants are artificial tooth roots implanted into the gums/jaws.

Request sample report @ https://www.alliedmarketresearch.com/request-toc-and-sample/1068

Rising incidence rates of dental caries and periodontal conditions has driven the dental implants and prosthetics market significantly. Rising incidences of complete as well as partial edentulism has also led to market growth. In addition, rising ageing population which is highly prone to tooth loss is another major driving factor. Apart from this, rising awareness and demand for tooth restorative technologies and focus on quality dental care will further propel the market growth. Conversely, limited dental insurance and reimbursement rates have hindered the market growth.

Send Enquiry About Drug Screening Market: https://www.alliedmarketresearch.com/purchase-enquiry/1068

World dental implants and prosthetics market is segmented on the basis of product, procedures, connectors, implant material, prosthetics and geography. On the basis of implant material, the dental implants can be metallic, ceramic, natural and polymeric. On the basis of product, the dental implants are classified as plate form dental implants and root form dental implants. On the basis of connectors dental implants are classified as internal hexagon connectors, external hexagon connectors and internal octagon connectors. Based on procedure, the market is segmented into endosteal (endosseous) implants and subperiosteal implants. Based on prosthetics, the market is segmented into dental bridges, dental crowns & bridges, dental dentures and dental abutments. Based upon geography, world dental implants and prosthetics market is segmented into North America, Europe, Asia-Pacific and LAMEA.

For any Queries Connect to Analyst: https://www.alliedmarketresearch.com/connect-to-analyst/1068

About Allied Market Research:

Allied Market Research (AMR) is a full-service market research and business-consulting wing of Allied Analytics LLP based in Portland, Oregon. Allied Market Research provides global enterprises as well as medium and small businesses with unmatched quality of “Market Research Reports” and “Business Intelligence Solutions”. AMR has a targeted view to provide business insights and consulting to assist its clients to make strategic business decisions and achieve sustainable growth in their respective market domain.

Breast Biopsy Market: Industry Analysis and Opportunity Assessment

Posted on Updated on

Summary: “World Breast Biopsy Market” includes Market Size, Share, Trends, Growth, Demand, Supply, Application, production, capacity utilization, supply, Analysis and Forecast

Breast Biopsy tests are used for diagnosing breast cancer and also act as a preventive screening method for the same and other ailments in breast, such as lump. The market is driven by increasing count of breast cancer, increasing awareness regarding breast cancer screening programs along with new reimbursement guidelines for biopsy procedures in the U.S. are the key factors that drive the growth of this market. Furthermore, increasing demand for breast surgeries that are minimally invasive is expected to boost the market growth. Various regulatory issues and risks of infection in breast biopsy procedures are key restraining factors that may hinder the growth of the market. Emerging countries is expected to offer abundant growth opportunities to the breast biopsy market.

Request Here for Sample Copy of Report: https://www.alliedmarketresearch.com/request-toc-and-sample/1067

The market is segmented on the basis of products, types, guidance and region. On the basis of product, the market is segmented into biopsy needles, guidance systems, biopsy tables, localization wires and others. On the basis of types, the market is segmented into needle breast biopsy and open surgical breast biopsy where the former is segmented into Core-Needle Biopsy (CNB), fine-needle aspiration biopsy (FNAB) and vacuum-assisted biopsy (VAB) while the latter is segmented into excisional breast biopsy and incisional breast biopsy. On the basis of guidance, the market is segmented into mammography-guided stereotactic breast biopsy, ultrasound-guided breast biopsy, MRI-guided breast biopsy and other guidance techniques. On the basis of region, the market is segmented into North America, Asia-Pacific, and Europe.

Request for Customization In Report: https://www.alliedmarketresearch.com/request-for-customization/1067

KEY BENEFITS FOR STAKEHOLDERS:

  • The report provides a comprehensive analysis of current & future market trends and emerging avenues for the growth of this market globally.
  • The report offers an overview of changing market dynamics in terms of fast turn-around analysis of stakeholders responses to recent industry policy changes and trends.
  • The report offers an insight into competitive landscape in terms of new technological developments, untapped segments, and value chain analysis.
  • This report entails the detailed quantitative analysis of the current market and estimations through 2014 and 2020, which assists in identifying the prevailing opportunities.
  • Recent developments in government policies on various segments is highlighted along with offering insight into the regulatory framework impacting the market.
  • The report offers strategic analysis of financial status of key market players, and highlights market share of key vendors.

View Detail Summary of this report: https://www.alliedmarketresearch.com/breast-biopsy-market

About Allied Market Research:

Allied Market Research (AMR) is a full-service market research and business-consulting wing of Allied Analytics LLP based in Portland, Oregon. Allied Market Research provides global enterprises as well as medium and small businesses with unmatched quality of “Market Research Reports” and “Business Intelligence Solutions”. AMR has a targeted view to provide business insights and consulting to assist its clients to make strategic business decisions and achieve sustainable growth in their respective market domain.

Breast Biopsy